Sanara MedTech to Report Q1 2026 Earnings on May 12

The medical technology company will host a conference call to discuss its latest quarterly results.

Apr. 14, 2026 at 11:53am

Got story updates? Submit your updates here. ›

A photorealistic studio still-life featuring polished metal surgical instruments, a glass vial, and a clean white bandage on a monochromatic grey background, symbolizing Sanara MedTech's focus on developing transformative surgical technologies.Sanara MedTech's innovative surgical products aim to enhance clinical outcomes and reduce healthcare costs.Fort Worth Today

Sanara MedTech Inc., a medical technology company focused on developing and commercializing transformative surgical technologies, announced it will report its first quarter 2026 financial results on Tuesday, May 12, 2026 before the U.S. financial markets open. The company will host a conference call and webcast on the same day at 8:00 a.m. Eastern Time to discuss the quarterly results and hold a Q&A session.

Why it matters

As a publicly traded medical technology company, Sanara MedTech's quarterly earnings reports provide insight into the performance and growth of its surgical product portfolio, which includes advanced biologic solutions and tissue repair grafts. The company's ability to drive innovation and commercialize new technologies is crucial for its long-term success in the competitive surgical market.

The details

Sanara MedTech will report its Q1 2026 results on May 12, 2026 before market open. The company will host a conference call and webcast at 8:00 a.m. Eastern Time on the same day to discuss the quarterly performance. A replay of the call will be available through May 26, 2026.

  • Sanara MedTech will report Q1 2026 financial results on May 12, 2026.
  • The company will host a conference call and webcast on May 12, 2026 at 8:00 a.m. Eastern Time.
  • A replay of the conference call will be available through May 26, 2026.

The players

Sanara MedTech Inc.

A medical technology company focused on developing and commercializing transformative surgical technologies to improve clinical outcomes and reduce healthcare costs.

Got photos? Submit your photos here. ›

What’s next

Investors and analysts will be closely watching Sanara MedTech's Q1 2026 earnings report and conference call for updates on the company's product pipeline, financial performance, and growth strategy.

The takeaway

As a publicly traded medical technology firm, Sanara MedTech's quarterly earnings are a key indicator of its ability to innovate and commercialize new surgical solutions that can drive improved patient outcomes and lower healthcare costs.